Approach to Paroxysmal Supraventricular Tachycardias

Published on 02/03/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4220 times

Chapter 20 Approach to Paroxysmal Supraventricular Tachycardias

Clinical Considerations

A “supraventricular” origin of a tachycardia implies the obligatory involvement of one or more cardiac structures above the bifurcation of the His bundle (HB), including the atrial myocardium, the atrioventricular node (AVN), the proximal HB, the coronary sinus (CS), the pulmonary veins (PVs), the venae cavae, or abnormal atrioventricular (AV) connections other than the HB (i.e., bypass tracts, BTs).1

Epidemiology

Narrow QRS complex supraventricular tachycardia (SVT) is a tachyarrhythmia with a rate greater than 100 beats/min and a QRS duration of less than 120 milliseconds. Narrow QRS complex SVTs include sinus tachycardia, inappropriate sinus tachycardia, sinoatrial nodal reentrant tachycardia, atrial tachycardia (AT), multifocal AT, atrial fibrillation (AF), atrial flutter (AFL), junctional ectopic tachycardia, nonparoxysmal junctional tachycardia, atrioventricular nodal reentrant tachycardia (AVNRT), and atrioventricular reentrant tachycardia (AVRT).

Narrow QRS complex tachycardias can be divided into those that require only atrial tissue for their initiation and maintenance (sinus tachycardia, AT, AF, and AFL), and those that require the AV junction (junctional tachycardia, AVNRT, and AVRT).

Paroxysmal SVT is the term generally applied to intermittent SVT other than AF, AFL, and multifocal AT. The major causes are AVNRT (approximately 50% to 60% of cases), AVRT (approximately 30% of cases), and AT (approximately 10% of cases).

Paroxysmal SVT with sudden onset and termination is relatively common; the estimated prevalence in the normal population is 2.25/1000, with an incidence of 35/100,000 person-years. Paroxysmal SVT in the absence of structural heart disease can present at any age but most commonly first presents between ages 12 and 30 years. Women have a twofold greater risk of developing this arrhythmia than men.

The mechanism of paroxysmal SVT is significantly influenced by both age and gender. In a large cohort of patients with symptomatic paroxysmal SVT referred for ablation, as patients grew older there was a significant and progressive decline in the number of patients presenting with AVRT, which was the predominant mechanism in the first decade, and a striking increase in AVNRT and AT (Fig. 20-1). These trends were similar in both genders, although AVNRT replaced AVRT as the predominant mechanism much earlier in women.2 The early predominance of AVRT is consistent with the congenital nature of the substrate and with the fact that symptom onset occurs earlier in patients with AVRT than AVNRT, most commonly in the first two decades of life. However, a minority of patients have relatively late onset of symptoms associated with AVRT and thus continue to account for a small proportion of ablations in older patients. Men account for a higher proportion of AVRT at all ages.

image

FIGURE 20-1 Proportion of paroxysmal supraventricular tachycardia mechanisms by age. AT = atrial tachycardia; AVNRT = atrioventricular nodal reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia.

(From Porter MJ, Morton JB, Denman R, et al: Influence of age and gender on the mechanism of supraventricular tachycardia, Heart Rhythm 1:393, 2004.)

AVNRT is the predominant mechanism overall in patients undergoing ablation and after the age of 20 years accounts for the largest number of ablations in each age group. AVNRT is unusual in children under 5 years of age, and typically initially manifests in early life, often in the teens. AVRT presents earlier, with an average of more than 10 years separating the time of clinical presentation of AVRT versus AVNRT. There is a striking 2:1 predominance of women in the AVNRT group, which remains without clear physiological or anatomical explanation. Female sex and older age, that is, teens versus early childhood years, favor the diagnosis of AVNRT over AVRT.3

ATs comprise a progressively greater proportion of those with paroxysmal SVT with increasing age, accounting for 23% of patients older than 70 years. Although there is a greater absolute number of women with AT, the proportion of AT in both genders is similar. Age-related changes in the atrial electrophysiological (EP) substrate (including cellular coupling and autonomic influences) can contribute to the increased incidence of AT in older individuals.

Clinical Presentation

The clinical syndrome of paroxysmal SVT is characterized as a regular rapid tachycardia of abrupt onset and termination. Episodes can last from seconds to several hours. Patients commonly describe palpitations and dizziness. Dizziness can occur initially because of hypotension, but it then disappears when the sympathetic response to the SVT stabilizes the blood pressure. Rapid ventricular rates can be associated with complaints of dyspnea, weakness, angina, or even frank syncope, and can at times be disabling. Neck pounding can occur during tachycardia because of simultaneous contraction of the atria and ventricles against closed mitral and tricuspid valves. The latter is more common in patients with typical AVNRT, occurring in approximately 50% of patients.

Patients often learn to use certain maneuvers such as carotid sinus massage or the Valsalva maneuver to terminate the arrhythmia, although many require pharmacological treatment to achieve this. In patients without structural heart disease, the physical examination is usually remarkable only for a rapid, regular heart rate. At times, because of the simultaneous contraction of atria and ventricles, cannon A waves can be seen in the jugular venous waveform (described as the “frog” sign). This clinical feature has been reported to distinguish paroxysmal SVT resulting from AVNRT from that caused by orthodromic AVRT. Although the atrial contraction during AVRT will occur against closed AV valves, the longer VA interval results in separate ventricular and then atrial contraction and a relatively lower right atrial (RA) and venous pressure; therefore, the presence of palpations in the neck is experienced less commonly (up to 17%) in patients with AVRT.3 In patients with an AT exhibiting AV block, usually of the Wenckebach type, the ventricular rate is irregular.

Initial Evaluation

History, physical examination, and an electrocardiogram (ECG) constitute an appropriate initial evaluation of paroxysmal SVT. However, clinical symptoms are not usually helpful in distinguishing different forms of paroxysmal SVT. A 12-lead ECG during tachycardia can be helpful for defining the mechanism of paroxysmal SVT. Ambulatory 24-hour Holter recording can be used for documentation of the arrhythmia in patients with frequent (i.e., several episodes per week) but self-terminating tachycardias. A cardiac event monitor is often more useful than a 24-hour recording in patients with less frequent arrhythmias. Implantable loop recorders can be helpful in selected cases with rare episodes associated with severe symptoms of hemodynamic instability (e.g., syncope).

An echocardiographic examination should be considered in patients with documented sustained SVT to exclude the possibility of structural heart disease. Exercise testing is rarely useful for diagnosis unless the arrhythmia is clearly triggered by exertion. Further diagnostic studies are indicated only if there are signs or symptoms that suggest structural heart disease.

Transesophageal atrial recordings and stimulation can be used in selected cases for diagnosis or to provoke paroxysmal tachyarrhythmias if the clinical history is insufficient or if other measures have failed to document an arrhythmia. Esophageal stimulation is not indicated if invasive EP investigation is planned. Invasive EP testing with subsequent catheter ablation may be used for diagnosis and therapy in cases with a clear history of paroxysmal regular palpitations. It may also be considered in patients with preexcitation or disabling symptoms without ECG documentation of an arrhythmia.

Principles of Management

Acute Management

Most episodes of paroxysmal SVT require intact 1:1 AVN conduction for continuation and are therefore classified as AVN-dependent. AVN conduction and refractoriness can be modified by vagal maneuvers and by many pharmacological agents and thus are the weak links targeted by most acute therapies. Termination of a sustained episode of SVT is usually accomplished by producing transient block in the AVN.

Vagal maneuvers such as carotid sinus massage, Valsalva maneuvers, or the dive reflex are usually used as the first step and generally terminate the SVT. Valsalva is the most effective technique in adults, but carotid sinus massage can also be effective. Facial immersion in water is the most reliable method in infants. Vagal maneuvers are less effective once a sympathetic response to paroxysmal SVT has become established, so patients should be advised to try them soon after onset of symptoms. Vagal maneuvers present the advantage of being relatively simple and noninvasive, but their efficacy seems to be lower compared with pharmacological interventions, with the incidence of paroxysmal SVT termination ranging from 6% to 22% following carotid sinus massage.

When vagal maneuvers are unsuccessful, termination can be achieved with antiarrhythmic drugs whose primary effects increase AVN refractoriness, decrease AVN conduction (negative dromotropic effect), or both. These drugs can have direct (e.g., verapamil and diltiazem block the slow inward calcium current of the AVN) or indirect effects (e.g., digoxin increases vagal tone to the AVN). In most patients, the drug of choice is either adenosine or verapamil.

The advantages of adenosine include its rapid onset of action (usually within 10 to 25 seconds via a peripheral vein), short half-life (<10 seconds), and high degree of efficacy. The effective dose of adenosine is usually 6 to 12 mg, given as a rapid bolus. Doses up to 12 mg terminate over 90% of paroxysmal SVT episodes. Sequential dosing can be given at 60-second intervals because of adenosine’s rapid metabolism. In AVNRT, termination is usually caused by block in the anterograde slow pathway. In AVRT, termination occurs secondary to block in the AVN. Termination can also occur indirectly, that is, because of adenosine-induced premature atrial complexes (PACs) or premature ventricular complexes (PVCs). Adenosine shortens the atrial refractory period, and atrial ectopy can induce AF. This can be dangerous if the patient has a BT capable of rapid anterograde conduction, and sometimes subsequently requires immediate electrical cardioversion. Because adenosine is cleared so rapidly, reinitiation of paroxysmal SVT after initial termination can occur. Either repeated administration of the same dose of adenosine or substitution of a calcium channel blocker will be effective.

The AVN action potential is calcium channel–dependent, and the non–dihydropyridine calcium channel blockers verapamil and diltiazem are effective for terminating AVN-dependent paroxysmal SVT. The recommended dosage of verapamil is 5 mg intravenously over 2 minutes, followed in 5 to 10 minutes by a second 5- to 7.5-mg dose. The recommended dose of diltiazem is 20 mg intravenously followed, if necessary, by a second dose of 25 to 35 mg. Paroxysmal SVT termination should occur within 5 minutes of the end of the infusion, and over 90% of patients with AVN-dependent paroxysmal SVT respond. As with adenosine, transient arrhythmias, including atrial and ventricular ectopy, AF, and bradycardia, can be seen after paroxysmal SVT termination with calcium channel blockers. Hypotension can occur with calcium channel blockers, particularly if the paroxysmal SVT does not terminate. Adenosine and verapamil have been reported to have a similar high efficacy in terminating paroxysmal SVT, with a rate of success ranging from 59% to 100% for adenosine and from 73% to 98.8% for verapamil, according to the dose and mode of administration. However, data also suggest that the efficacy of adenosine and verapamil is affected by the arrhythmia rate. Increasing SVT rates are significantly associated with higher percentages of sinus rhythm restoration following treatment with adenosine. In contrast, the efficacy of verapamil in restoring sinus rhythm was inversely related to the rate of paroxysmal SVT.4

Intravenous beta blockers including propranolol (1 to 3 mg), metoprolol (5 mg), and esmolol (500 µg/kg over 1 minute and a 50-µg/kg/min infusion) are also useful for acute termination. Digoxin (0.5 to 1.0 mg) is considered the least effective of the four categories of drugs available, but is a useful alternative when there is a contraindication to the other agents.

AVN-dependent paroxysmal SVT can present with a wide QRS complex in patients with fixed or functional aberration, or if a BT is used for anterograde conduction. Most wide complex tachycardias, however, are caused by mechanisms that can worsen after intravenous administration of adenosine and calcium channel blockers. Unless there is strong evidence that a wide QRS tachycardia is AVN-dependent, adenosine, verapamil, and diltiazem should not be used.

Limited data are available on the acute pharmacological therapy of ATs. Automatic or triggered tachycardias and sinus node reentry should respond to adenosine, verapamil, diltiazem, or beta-adrenergic blockers. Other ATs can respond to class I or III antiarrhythmic drugs given orally or parenterally.

Chronic Management

Because most paroxysmal SVTs are generally benign arrhythmias that do not influence survival, the main reason for treatment is to alleviate symptoms. The threshold for initiation of therapy and the decision to treat SVT with oral antiarrhythmic drugs or catheter ablation depends on the frequency and duration of the arrhythmia, severity of symptoms, and patient preference. The threshold for treatment will also reflect whether the patient is a competitive athlete, a woman considering pregnancy, or someone with a high-risk occupation. Catheter ablation is an especially attractive option for patients who desire to avoid or are unresponsive or intolerant to drug therapy.

For patients requiring therapy who are reluctant to undergo catheter ablation, antiarrhythmic drug therapy remains a viable alternative. For AVN-dependent paroxysmal SVT, calcium channel blockers and beta blockers will improve symptoms in 60% to 80% of patients. A comparison of verapamil, propranolol, and digoxin has shown equivalent efficacy in a small group of patients. However, in general, calcium channel blockers and beta blockers are preferred to digoxin. In patients who do not respond, class IC and III drugs can be considered. Flecainide and propafenone affect the AVN and BTs and reduce SVT frequency. Sotalol, dofetilide, and amiodarone are second-line agents. Because sympathetic stimulation can antagonize the effects of many antiarrhythmic agents, concomitant therapy with a beta blocker can improve efficacy.

Patients with well-tolerated episodes of paroxysmal SVT that always terminate spontaneously or with vagal maneuvers do not require chronic prophylactic therapy. Selected patients may be treated only for acute episodes. Outpatients may use a single oral dose of verapamil, propranolol, or propafenone to terminate an episode of AVRT or AVNRT effectively. This so-called “pill in the pocket” or “cocktail therapy” is a reasonable treatment option for patients who have tachycardia episodes that are sustained but infrequent enough that daily preventive therapy is not desired. Oral antiarrhythmic drug tablets are not reliably absorbed during rapid paroxysmal SVT, but some patients can respond to self-administration of crushed medications.

Pharmacological management of ATs has not been well evaluated in controlled clinical trials. Depending on the mechanism responsible for the arrhythmia, beta blockers, calcium channel blockers, and class I or III antiarrhythmic drugs may reduce or eliminate symptoms.

Electrocardiographic Features

Assessment of Regularity of the Supraventricular Tachycardia

Most SVTs are associated with a regular ventricular rate. If the rhythm is irregular, the ECG should be scrutinized for discrete atrial activity and for any evidence of a pattern to the irregularity (e.g., grouped beating typical of Wenckebach periodicity). If the rhythm is irregularly irregular (i.e., no pattern can be detected), the mechanism of the arrhythmia is either multifocal AT or AF (Fig. 20-2). Multifocal AT is an irregularly irregular atrial rhythm characterized by more than three different P wave morphologies, with the P waves separated by isoelectric intervals and associated with varying P-P, R-R, and PR intervals (see Fig. 11-1). On the other hand, AF is characterized by rapid and irregular atrial fibrillatory activity and, in the presence of normal AVN conduction, by an irregularly irregular ventricular response. P waves cannot be detected in AF, although coarse fibrillatory waves and prominent U waves can sometimes give the appearance of P waves. At times, the fibrillatory activity is so fine as to be undetectable.

image

FIGURE 20-2 Differential diagnosis of narrow QRS tachycardia. AF = atrial fibrillation; AFL = atrial flutter; AT = atrial tachycardia; AV = atrioventricular; AVNRT = atrioventricular nodal reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia; PJRT = permanent junctional reciprocating tachycardia.

(From Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al: American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines [Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias]: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines [Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias], Circulation;108:1871, 2003.)

Atrial Activity

Identification

If the patient’s rhythm is regular or has a clearly discernible pattern, the ECG should next be assessed for P waves (atrial activity).5 The P waves may be easily discernible; however, frequently, comparison with a normal baseline ECG is needed and can reveal a slight alteration in the QRS, ST segment, or T waves, suggesting the presence of the P wave. If the P waves cannot be clearly identified, carotid sinus massage or the administration of intravenous adenosine may help clarify the diagnosis. These maneuvers may also terminate the SVT.

Termination of the Arrhythmia

Carotid sinus massage or adenosine can terminate the SVT, especially if the rhythm is AVNRT or AVRT. A continuous ECG tracing should be recorded during these maneuvers, because the response can aid in the diagnosis.5 Termination of the tachycardia with a P wave after the last QRS complex is most common in AVRT and typical AVNRT and is rarely seen with AT (see Fig. 18-22), whereas termination of the tachycardia with a QRS complex is more common with AT, atypical AVNRT, and permanent junctional reciprocating tachycardia (PJRT; see Fig. 18-19). If the tachycardia continues despite development of AV block, the rhythm is almost certainly AT or AFL; AVRT is excluded and AVNRT is very unlikely.

Characterization of the P/Qrs Relationship

Electrophysiological Testing

Discussion in this section will focus on differential diagnosis of narrow QRS complex paroxysmal SVTs, including AT, orthodromic AVRT, and AVNRT. The goals of EP testing in these patients include the following: (1) evaluation of baseline cardiac electrophysiology; (2) induction of SVT; (3) evaluation of the mode of initiation of the SVT; (4) definition of atrial activation sequence during the SVT; (5) definition of the relationship of the P wave to the QRS at the onset and during the SVT; (6) evaluation of the effect of BBB on the tachycardia cycle length (CL) and ventriculoatrial (VA) interval; (7) evaluation of the SVT circuit and requirement for the atria, His bundle (HB), and/or ventricles in the initiation and maintenance of the SVT; (8) evaluation of the SVT response to programmed electrical stimulation and overdrive pacing from the atrium and ventricle; and (9) evaluation of the effects of drugs and physiological maneuvers on the SVT.

Programmed Electrical Stimulation during Normal Sinus Rhythm

The programmed stimulation protocol should include (1) ventricular burst pacing from the right ventricular (RV) apex (down to pacing CL at which VA block develops); (2) single and double ventricular extrastimuli (VESs, down to the ventricular effective refractory period, ERP) at multiple CLs (600 to 400 milliseconds) from the RV apex; (3) atrial burst pacing from the high right atrium (RA) and coronary sinus (CS; down to the pacing CL at which 2:1 atrial capture occurs); (4) single and double atrial extrastimuli (AESs, down to the atrial ERP) at multiple CLs (600 to 400 milliseconds) from the high RA and CS; and (5) administration of isoproterenol infusion (0.5 to 4 µg/min) as needed to facilitate tachycardia induction.

Atrial Extrastimulation and Atrial Pacing During Normal Sinus Rhythm

Extra Atrial Beats

AES and atrial pacing can trigger extra atrial beats or echo beats. Those beats can be caused by different mechanisms.

Atrioventricular Nodal Echo Beats

These beats occur in the presence of anterograde dual AVN physiology (see Fig. 4-23). Such beats require anterograde block of the atrial stimulus in the fast AVN pathway, anterograde conduction down the slow pathway, and then retrograde conduction up the fast pathway. AVN echo beats have several features: they appear reproducibly after a critical AH interval; the atrial activation sequence is consistent with retrograde conduction over the fast pathway, with the earliest atrial activation site in the HB; and the VA interval is very short, but it can be longer if the atrial stimulus causes anterograde concealment (and not just block) in the fast pathway.

Atrioventricular Echo Beats

AV echo beats occur secondary to anterograde conduction of the atrial stimulus over the AVN-HPS and retrograde conduction over an AV BT (concealed or bidirectional BT). If preexcitation is manifest during atrial stimulation, the last atrial impulse inducing the echo beat will demonstrate loss of preexcitation because of anterograde block in the AV BT, and atrial activation sequence and P wave morphology of the echo beat will depend on the location of the BT (see Fig. 3-10). These beats have a relatively short VA interval, but always longer than 70 milliseconds. Moreover, the VA interval of the AV echo beat remains constant, regardless of the varying coupling interval of the AES triggering the echo beat (VA linking). Alternatively, AV echo beats can occur secondary to anterograde conduction of the atrial stimulus over a manifest AV BT and retrograde conduction over an AVN, in which setting the last paced beat is associated with anterograde block in the AVN and fully preexcited QRS complex.

Ventricular Extrastimulation and Ventricular Pacing During Normal Sinus Rhythm

Retrograde Atrial Activation Sequence

VA conduction over the AVN produces a classic concentric atrial activation sequence starting in the anteroseptal or posteroseptal region of the RA because of retrograde conduction over either the fast or the slow AVN pathways, respectively. In the presence of a retrogradely conducting AV BT, atrial activation can result from conduction over the AV BT, over the AVN, or a fusion of both (see Fig. 18-16). An eccentric atrial activation sequence in response to ventricular stimulation suggests the presence of an AV BT mediating VA conduction (see Fig. 18-16). The presence of a concentric retrograde atrial activation sequence, however, does not exclude the presence of a retrogradely conducting BT that could be septal in location or located far from the pacing site, allowing for preferential VA conduction over the AVN.

Extra Ventricular Beats

Ventricular stimulation can trigger extra ventricular beats or echo beats. These beats can be caused by different mechanisms.

Right Bundle Branch Block during Ventricular Extrastimulation

During the delivery of progressively premature single VESs, an abrupt increase in the VA conduction interval is often seen. This may be due to a variety of reasons including a change in activation from a BT block to the AVN or a change from fast to slow pathway conduction, or it may be the result of an abrupt change when the refractory period of the RB has been reached.

Retrograde RBBB occurs frequently during VES testing, and can be diagnosed by observing the retrograde His potential during the drive train and its abrupt displacement with the VES. Often, however, it is difficult to visualize the retrograde His potential during the pacing train; even then, the sudden appearance of an easily distinguished retrograde His potential, separate from the ventricular electrogram, may be sufficient to recognize retrograde RBBB.

The VH interval prolongation occurs because, following RBBB, conduction must traverse the interventricular septum (which requires approximately 60 to 70 milliseconds in normal hearts), enter retrogradely via the LB, and ascend to reach the HB. Although an increase in the VH interval necessarily occurs with retrograde RBBB, whether a similar increase occurs in the VA interval depends on the nature of VA conduction. Measurement of the retrograde VH and VA intervals on development of retrograde RBBB during VES can help the distinction between retrograde AVN and BT conduction.

In the absence of a BT, the AVN can be activated in a retrograde fashion only after retrograde activation of the HB; as a consequence, VA activation will necessarily be delayed with retrograde RBBB, and the increase in the VA interval will be at least as much as the increase in the VH interval. In contrast, when retrograde conduction is via a BT, there will be no expected increase in the VA interval when retrograde RBBB is induced. Thus, the increase in the VA interval is minimal and always less than the increase in the VH interval.8

Induction of Tachycardia

Initiation by Atrial Extrastimulation or Atrial Pacing

Inducibility

All types of paroxysmal SVTs can be inducible with atrial stimulation (except automatic AT). SVT initiation that is reproducibly dependent on a critical AH interval is classic for typical AVNRT (see Fig. 17-8). Atypical AVNRT is usually initiated with modest prolongation of the AH interval along the fast pathway with anterograde block in the slow pathway, followed by retrograde slow conduction over the slow pathway. Therefore, a critical AH interval delay is not obvious (see Fig. 17-10). AT initiation also can be associated with AV delay, but that is not a prerequisite for initiation. Orthodromic AVRT usually requires some AV delay for initiation; however, the delay can occur anywhere along the AVN-HPS axis. In patients with baseline manifest preexcitation, initiation of orthodromic AVRT is usually associated with anterograde block in the AV BT and loss of preexcitation following the initiating atrial stimulus, which would then allow that BT to conduct retrogradely during the SVT.9 Initiation may require catecholamines (isoproterenol) with any type of SVT, and this observation does not help for differential diagnosis.

Tachycardia Features

Atrial Activation Sequence

During typical AVNRT, the initial site of atrial activation is usually recorded in the HB catheter at the apex of the triangle of Koch.10 In contrast, the initial site of atrial activation during atypical AVNRT is usually recorded at the base of the triangle of Koch or coronary sinus ostium (CS os) (see Fig. 17-5).10 On the other hand, in orthodromic AVRT, the initial site of atrial activation depends on the location of the AV BT, but is always near the AV groove, without multiple breakthrough points. It is comparable to that during ventricular pacing when VA conduction occurs exclusively over the AV BT. The atrial activation sequence during AT depends on the origin of the AT, and can simulate that of other types of SVTs. In summary, eccentric atrial activation during SVT excludes typical and atypical AVNRT, except for the left variant of AVNRT, during which the earliest atrial activation occurs in the proximal or mid-CS. Moreover, an eccentric atrial activation sequence that originates away from the AV rings is diagnostic of AT and excludes both AVNRT and AVRT.9

Atrial-Ventricular Relationship

Atrioventricular Block

The presence of AV block during SVT excludes AVRT, is uncommon during AVNRT, and strongly favors AT (Fig. 20-3). AV block occurs commonly during AT, with either Wenckebach periodicity or fixed-ratio block. AV block may also occur during AVNRT because of block below the reentry circuit, usually below the HB and infrequently in the lower common pathway, which can occur especially at the onset of the SVT, during acceleration of the SVT, and following a PVC or a VES (see Fig. 17-4).

Variation of the P/QRS Relationship

Spontaneous changes in the PR and RP intervals with fixed A-A interval favor AT and exclude orthodromic AVRT (Fig. 20-4, see Fig. 11-13). On the other hand, spontaneous changes in tachycardia CL accompanied by constant VA interval suggest orthodromic AVRT (see Fig. 18-22). During orthodromic AVRT, the RP interval remains fixed, regardless of oscillations in tachycardia CL from whatever cause or changes in the PR (AH) interval. Thus, the RP/PR ratio may change, and the tachycardia CL is most closely associated with the PR interval (i.e., anterograde slow conduction). Variation of the P/QRS relationship (with changes in the AH interval, HA interval, and AH/HA ratio), with or without block, can occur during AVNRT, especially in atypical or slow-slow AVNRT. This phenomenon usually occurs when the conduction system, the reentry circuit, or both are unstable during initiation or termination of the tachycardia or in cases of nonsustained tachycardias. The ECG manifestation of P/QRS variations, with or without AV block during tachycardia, should not be misdiagnosed as AT; they can be atypical or, rarely, typical forms of AVNRT. Moreover, the variations could be of such magnitude that a long RP tachycardia can masquerade for brief periods of time as short RP tachycardia.

Oscillation in Tachycardia Cycle Length

Analysis of tachycardia CL variability can provide useful diagnostic information that is available even when episodes of SVT are nonsustained. SVT CL variability of at least 15 milliseconds in magnitude was found to occur in up to 73% of paroxysmal SVTs and was equally prevalent in AT, AVNRT, and orthodromic AVRT. Changes in atrial CL preceding similar changes in subsequent ventricular CL strongly favor AT or atypical AVNRT (see Fig. 17-14). In contrast, when the change in atrial CL is predicted by the change in preceding ventricular CL, typical AVNRT or orthodromic AVRT is the most likely mechanism (see Fig. 18-22).

The AVN participates either actively or passively in all types of SVTs and the AV interval can vary depending on the preceding atrial CL and autonomic tone. A change in anterograde or retrograde AVN conduction can result in tachycardia CL variability in AVNRT or orthodromic AVRT. In contrast, CL variability in AT is a result of changes in the CL of the atrial reentrant or focal tachycardia, or changes in AVN conduction. Therefore, when there is CL variability in both the atrium and ventricle, changes in atrial CL during AT would be expected to precede and predict the changes in ventricular CL. However, ventricular CL variability can be caused by changes in AV conduction instead of changes in the CL of an AT, in which case ventricular CL variability may not be predicted by a prior change in atrial CL during AT. Nevertheless, because there is no VA conduction during AT, ventricular CL variability by itself would not be expected to result in atrial CL variability during AT.

In contrast to AT, typical AVNRT and orthodromic AVRT generally have CL variability because of changes in anterograde AVN conduction. Because retrograde conduction through a fast AVN pathway or a BT generally is much less variable than anterograde conduction through the AVN, the changes in ventricular CL that result from variability in anterograde AVN conduction would be expected to precede the subsequent changes in atrial CL. This explains why the change in atrial CL does not predict the change in subsequent ventricular CL in typical AVNRT and orthodromic AVRT. On the other hand, in atypical AVNRT, anterograde conduction occurs over the more stable fast AVN pathway and retrograde conduction is more subject to variability. This explains the finding that changes in atrial CL predict the changes in subsequent ventricular CL in atypical AVNRT, as was the case in AT.

Effects of Bundle Branch Block

The development of BBB during SVT that neither influences the tachycardia CL (A-A or H-H interval) nor the VA interval is consistent with AT, AVNRT (see Fig. 17-4), and orthodromic AVRT using a BT in the ventricle contralateral to the BBB (see Fig. 18-21), but excludes orthodromic AVRT using a BT ipsilateral to the BBB.

BBB ipsilateral to the AV BT mediating orthodromic AVRT results in prolongation of the surface VA interval because of the extra time required for the impulse to travel from the AVN down the HB and contralateral bundle branch, and transseptally to the ipsilateral ventricle to reach the AV BT and then activate the atrium (see Fig. 18-23). However, the local VA interval (measured at the site of BT insertion) remains constant. Additionally, the tachycardia CL usually increases in concordance with the increase in the surface VA interval as a result of ipsilateral BBB, because of the now-larger tachycardia circuit; however, because the time the wavefront spends outside the AVN is now longer, AVN conduction may improve, resulting in shortening in the AH interval (PR interval), which can be of a magnitude sufficient to overcome the prolongation of the VA interval. This can consequently result in shortening in the tachycardia CL. Thus, the surface VA interval and not the tachycardia CL should be used to assess the effects of BBB on the SVT (see Fig. 18-9).

Prolongation of the VA interval during SVT in response to BBB by more than 35 milliseconds indicates that an ipsilateral free wall AV BT is present and is participating in the SVT (i.e., diagnostic of orthodromic AVRT). On the other hand, prolongation of the surface VA by more than 25 milliseconds suggests a septal AV BT (posteroseptal AV BT in association with LBBB, and superoparaseptal AV BT in association with RBBB; see Fig. 18-24). In contrast, BBB contralateral to the AV BT does not influence the VA interval or tachycardia CL because the contralateral ventricle is not part of the reentrant circuit (see Figs. 18-21 and 18-23).

Since the occurrence of BBB during SVT is much more common in orthodromic AVRT than AVNRT or AT (90% of SVTs with sustained LBBB are orthodromic AVRTs), the mere presence of LBBB aberrancy during SVT is suggestive of orthodromic AVRT, but can still occur in other types of SVTs.6,9

Termination and Response to Physiological and Pharmacological Maneuvers

Termination with Adenosine

The mere termination of SVT in response to adenosine is usually not helpful in differentiating SVTs. However, the pattern of SVT termination can be helpful in two situations: First, reproducible termination of the SVT with a QRS not followed by a P wave excludes orthodromic AVRT using a rapidly conducting AV BT as the retrograde limb (adenosine blocks the AVN and not the BT), is unusual in typical AVNRT (adenosine blocks the slow pathway but does not affect the fast pathway), and is consistent with AT, PJRT, or atypical AVNRT. Second, reproducible termination of the SVT with a P wave not followed by a QRS excludes AT, because it occurs in AT only if adenosine terminates the AT at the same moment it causes AV block, which is an unlikely coincidence (Fig. 20-5). Most ATs (50% to 80%) can be terminated by adenosine, typically (80%) prior to the onset of AV block. Response to adenosine does not help differentiate between atypical AVNRT and PJRT.

Diagnostic Maneuvers during Tachycardia

Atrial Extrastimulation During Supraventricular Tachycardia

Atrial Pacing During Supraventricular Tachycardia

Entrainment

Overdrive atrial pacing can entrain reentrant AT, AVNRT, and orthodromic AVRT but not triggered activity or automatic ATs. Entrainment with manifest fusion, on the other hand, can be seen only in AVRT and macroreentrant AT, but not with AVNRT or focal AT (see Fig. 18-27). However, it is important to understand that overdrive pacing of focal AT and AVNRT can result in a certain degree of fusion, especially when the pacing CL is only slightly shorter than the tachycardia CL. Such fusion, however, is unstable during the same pacing drive at a constant CL, because the pacing stimuli fall on a progressively earlier portion of the tachycardia cycle, producing progressively less fusion and more fully paced morphology. Such phenomena should be distinguished from entrainment, and sometimes this requires pacing for long intervals to demonstrate variable degrees of fusion.

During entrainment at a pacing CL close to the tachycardia CL, the AH interval during entrainment is longer than that during AVNRT because the atrium and HB are activated in parallel during AVNRT and in sequence during atrial pacing entraining the AVNRT (because of the presence of an upper common pathway). In contrast, in the setting of AT and orthodromic AVRT, the AH interval is comparable during SVT and entrainment with atrial pacing.9

Ventriculoatrial Linking

On cessation of overdrive atrial pacing, if the VA interval following the last entrained QRS is reproducibly constant (<10 milliseconds in variation), despite pacing at different CLs or for different durations (“VA linking”) and is similar to that during SVT, AT is unlikely. If no VA linking is demonstrable, AT is more likely than other types of SVTs (see Fig. 18-27).6 VA linking occurs in the setting of typical AVNRT and orthodromic AVRT because the timing of atrial activation is dependent on the preceding ventricular activation and is the result of retrograde VA conduction over the AVN fast pathway (during typical AVNRT) or the AV BT (during orthodromic AVRT), which is relatively fixed and constant. Contrariwise, following cessation of overdrive pacing (with 1:1 AV conduction) during focal AT, the VA interval can vary significantly from the VA interval during AT, because the timing of the tachycardia atrial return cycle is not related to the preceding QRS.2,6

Differential-Site Atrial Pacing

As discussed in Chapter 11, differential site atrial pacing can help distinguish AT from other mechanisms of SVT. When the ΔVA interval (i.e., the maximal difference in the post-pacing VA intervals following cessation of pacing from the high RA and proximal CS) is more than 14 milliseconds, AT is suggested. On the other hand, in orthodromic AVRT and AVNRT, the initial atrial complex following cessation of atrial pacing entraining the SVT is linked to, and cannot be dissociated from, the last captured ventricular complex; hence, the ΔVA interval is typically less than 14 milliseconds.14

Ventricular Extrastimulation During Supraventricular Tachycardia

Resetting

During orthodromic AVRT, a VES can usually reset the SVT. However, the ability of the VES to affect the SVT depends on the distance between the site of ventricular stimulation to the ventricular insertion site of the BT and on the VES coupling interval. Because only parts of the ventricle ipsilateral to the BT are requisite components of the orthodromic AVRT circuit, a VES delivered in the contralateral ventricle may not affect the circuit (see Fig. 18-29). On the other hand, the inability of early single or double VESs to reset the SVT despite advancement of all ventricular electrograms (including the local electrogram in the electrode recording the earliest atrial activation during the SVT, which would be close to the potential BT ventricular insertion site) by more than 30 milliseconds excludes orthodromic AVRT. Several other findings can help confirm the presence of BT function and whether it is participating in the SVT or is only a bystander (see Tables 18-4 and 18-5).

For AVNRT, the ability of a VES to affect the SVT depends on its ability to activate the HB prematurely and penetrate the AVN, which in turn depends on the tachycardia CL, local ventricular ERP, and the time needed for the VES to reach the HB. Even when HB activation is advanced by the VES, the ability of the paced impulse to invade the AVN will depend on the length of the lower common pathway; the longer the lower common pathway, the more the timing of HB activation must be advanced. In fast-slow or slow-slow AVNRT, which typically has a long lower common pathway, the HB activation must be advanced by more than 30 to 60 milliseconds. In contrast, in slow-fast AVNRT, the lower common pathway is shorter and the tachycardia is typically reset by the VES as soon as the HB activation is advanced. Therefore, a late VES, delivered when the HB is refractory, would not be able to penetrate the AVN and reset AVNRT. During AT, a VES can advance the next atrial activation when given the chance to conduct retrogradely and prematurely to the atrium. However, it would never be able to delay the next AT beat.

Although resetting the SVT by a VES is not diagnostic by itself of a specific type of SVT, it can be helpful in certain situations. First, the ability of a late VES delivered while the HB is refractory (i.e., when the anterograde His potential is already manifest or within 35 to 55 milliseconds before the time of the expected His potential) to affect (reset or terminate) the SVT excludes AVNRT, because such a VES would not have been able to penetrate the AVNRT circuit (Fig. 20-6; and see Fig. 18-29). It also excludes AT, except for cases of AT associated with the presence of innocent bystander BT, in which case the presence of such a BT is usually easy to exclude with ventricular pacing during NSR. Second, the ability of a VES to delay the next atrial activation excludes AT (see Fig. 18-26). Third, the ability of a VES to reset the SVT without atrial activation (i.e., the VES advances the subsequent His potential and QRS and blocks in the upper common pathway) excludes AT and orthodromic AVRT, because it proves that the atrium is not part of the SVT circuit. Fourth, failure of early single or double VESs to reset the SVT, despite advancement of ventricular electrograms in the electrode recording the earliest atrial activation by more than 30 milliseconds, excludes orthodromic AVRT. Fifth, resetting with manifest QRS fusion can be observed during orthodromic AVRT, especially during pacing at a site closer to the BT ventricular insertion site than the entrance of the reentrant circuit to ventricular tissue (i.e., the HPS). Such a phenomenon, on the other hand, cannot occur during AVNRT or focal AT because of the lack of spatial separation of the entrance and exit to the tachycardia circuit. Sixth, retrograde atrial activation sequence following a VES that resets the tachycardia is usually similar to that during SVT in the setting of AVNRT and orthodromic AVRT, because it should conduct over the tachycardia retrograde limb (except in the presence of a bystander retrogradely conducting AV BT). In contrast, a retrograde atrial activation sequence during the VES is usually different from that during AT, except for ATs originating close to the AV junction.

Termination

Termination of AVNRT with a single VES is difficult and occurs rarely when the tachycardia CL is less than 350 milliseconds; such termination favors the diagnosis of orthodromic AVRT, which can usually be readily terminated by single or double VESs. Termination of the SVT with a VES delivered when the HB is refractory excludes AVNRT (see Fig. 20-6). It also excludes AT, except for cases of AT associated with the presence of an innocent bystander BT mediating VA conduction. Reproducible termination of the SVT with a VES not followed by atrial activation excludes AT (see Fig. 18-29) and, if this occurs with a VES delivered while the HB is refractory, it excludes both AT and AVNRT (see Fig. 20-6).

Ventricular Pacing During SUPRAVENTRICULAR TACHYCARDIA

Ventricular pacing is performed at a CL 10 to 30 milliseconds shorter than the tachycardia CL; the pacing CL is then progressively reduced by 10 to 20 milliseconds in a stepwise fashion with discontinuation of ventricular pacing after each pacing CL to verify continuation versus termination of the SVT. The presence of ventricular capture during ventricular pacing should be verified. Additionally, the presence of 1:1 VA conduction and acceleration of the atrial rate to the pacing CL should be carefully examined (Fig. 20-7). It is also important to verify the continuation of the SVT following cessation of ventricular pacing and whether SVT termination, with or without reinduction of the SVT, has occurred during ventricular pacing.

Entrainment

Ventricular pacing is almost always able to entrain AVNRT and orthodromic AVRT and, if 1:1 VA conduction is maintained, reentrant AT. Entrainment of the SVT by RV pacing can help differentiate orthodromic AVRT from AVNRT by evaluating the VA interval during SVT versus that during pacing, and also by evaluating the post-pacing interval (PPI). The ventricle and atrium are activated in sequence during orthodromic AVRT and during ventricular pacing, but in parallel during AVNRT. Therefore, the VA interval during orthodromic AVRT approximates that during ventricular pacing (see Fig. 18-30). In contrast, the VA interval during AVNRT would be much shorter than that during ventricular pacing (see Fig. 17-18). In general, a difference in the VA interval (ΔVA [VApacing – VASVT]) greater than 85 milliseconds is consistent with AVNRT, whereas a ΔVA of less than 85 milliseconds is consistent with orthodromic AVRT (Fig. 20-8).

image

FIGURE 20-8 Entrainment of narrow QRS supraventricular tachycardia (SVT) with right ventricular (RV) apical pacing. Several features in this tracing can help in the differential diagnosis of the SVT. First, atrial and ventricular activation occur simultaneously during the SVT, which excludes atrioventricular reentrant tachycardia (AVRT). Second, atrial activation during the SVT is eccentric, with earliest activation in the mid–coronary sinus (CS), which favors atrial tachycardia (AT) over AVNRT. Third, the atrial activation sequence during ventricular pacing is identical to that during SVT, which favors AVNRT and AVRT over AT. Fourth, following cessation over ventricular pacing, the post-pacing interval (PPI) minus SVT cycle length (CL), [PPI – SVT CL], is more than 115 milliseconds, and the ΔVA interval (VApacing – VASVT) is more than 85 milliseconds, which favors AVNRT over AVRT. Fifth, although characterization of the activation sequence following cessation of ventricular pacing (A-A-V versus A-V response) is unclear (because of the simultaneous occurrence of atrial and ventricular activation in the first tachycardia complex, replacing ventricular activation with HB activation [i.e., characterizing the response as A-A-H or A-H instead of A-A-V or A-V, respectively]) reveals an A-H response, which favors AVRT and AVNRT over AT. In summary, AVRT can be reliably excluded by the simultaneous atrial and ventricular activation. AT is excluded by the A-H response following cessation of ventricular pacing and by the identical atrial activation sequence during the SVT and ventricular pacing. The left variant of typical AVRT (with an eccentric atrial activation sequence) is the mechanism of the SVT.

Additionally, the PPI after entrainment of AVNRT from the RV apex is significantly longer than the tachycardia CL (the [PPI – SVT CL] difference is usually >115 milliseconds), because the reentrant circuit in AVNRT is above the ventricle and far from the pacing site (see Fig. 17-18). In AVNRT, the PPI reflects the conduction time from the pacing site through the RV muscle and HPS, once around the reentry circuit and back to the pacing site. Therefore, the difference between the PPI and the SVT CL [PPI – SVT CL] reflects twice the sum of the conduction time through the RV muscle, the HPS, and any lower common pathway (see Fig. 20-8). In orthodromic AVRT using a septal BT, the PPI reflects the conduction time through the RV to the septum, once around the reentry circuit and back. In other words, the [PPI – SVT CL] reflects twice the conduction time from the pacing catheter through the ventricular myocardium to the reentry circuit. Therefore, the PPI more closely approximates the SVT CL in orthodromic AVRT using a septal BT, compared with AVNRT (see Fig. 18-30). This maneuver was studied specifically for differentiation between atypical AVNRT and orthodromic AVRT, but the principle also applies to typical AVNRT. In general, a [PPI – SVT CL] difference greater than 115 milliseconds is consistent with AVNRT, whereas a [PPI – SVT CL] difference greater than 115 milliseconds is consistent with orthodromic AVRT. For borderline values, ventricular pacing at the RV base can help exaggerate the difference between the PPI and tachycardia CL in the setting of AVNRT, but without significant changes in the setting of orthodromic AVRT, because the site of pacing at the RV base is farther from the AVNRT circuit than the RV apex (because the paced wavefront has to travel first to the RV apex before engaging the HPS and conducting retrogradely to the AVN), but is still close to an AVRT circuit using a septal BT (and, in fact, it is closer to the ventricular insertion of the BT).15,16

However, there are several potential pitfalls to the criteria discussed above. The tachycardia CL and VA interval are often perturbed for a few cycles after entrainment. For this reason, care should be taken not to measure unstable intervals immediately after ventricular pacing. In addition, spontaneous oscillations in the tachycardia CL and VA intervals can be seen. The discriminant points chosen may not apply when the spontaneous variability is more than 30 milliseconds. Also, it is possible to mistake isorhythmic VA dissociation for entrainment if the pacing train is not long enough or the pacing CL is too close to the tachycardia CL. Finally, those criteria may not apply to BTs with significant decremental properties, although small decremental intervals are unlikely to provide a false result.

Another limitation is that the [PPI – SVT CL] difference does not account for potential decremental anterograde AVN conduction that may be induced by overdrive pacing, which can significantly affect diagnostic interpretations of the PPI. The prolonged AH interval on the last entrained beat will contribute to prolongation of the PPI that is not reflective of the distance of the pacing site from the circuit. Thus, [PPI – SVT CL] differences obtained after entrainment of orthodromic AVRT employing a septal BT can actually overlap with those observed after entrainment of AVNRT. Correction of the [PPI – SVT CL] difference for the degree of decrement in the AVN (by subtracting the difference in AH [or AV] interval during tachycardia and on the return cycle from the [PPI – SVT CL]) has been shown to improve the accuracy of this criterion for distinction between AVNRT and orthodromic AVRT. In a study of patients with both typical and atypical forms of AVNRT, as well as orthodromic using septal and free wall BTs, a corrected [PPI – SVT CL] difference of less than 110 milliseconds was found more accurate in identifying orthodromic AVRT from AVNRT than the uncorrected [PPI – SVT CL] difference. The use of change in VA interval is of course not influenced by prolongation of the AV interval during pacing and does not require correction.15,17,18

Differential Right Ventricular Entrainment

Differential-site RV entrainment (from RV apex versus RV base) can help distinguish AVNRT from orthodromic AVRT. As discussed in Chapter 17, after entrainment of AVNRT, the PPI following entrainment from the RV base is longer than that post entrainment from the RV apex. Conversely, in orthodromic AVRT, the PPI tends to be similar, irrespective of the site of RV pacing.19 To avoid potential errors introduced by decremental conduction within the AVN during RV pacing, it is preferable to perform correction of the PPI (by subtracting any increase in the AV interval of the return cycle beat, as compared with the AV interval during SVT). A differential corrected [PPI – SVT CL] of more than 30 milliseconds after transient entrainment (i.e., corrected PPI following pacing from the RV base being consistently ≥30 milliseconds longer than that following pacing from the RV apex) is consistent with AVNRT, whereas a differential corrected [PPI – SVT CL] of less than 30 milliseconds is consistent with orthodromic AVRT. Additionally, a differential VA interval (ventricular stimulus-to-atrial interval during entrainment from RV base versus RV septum) of more than 20 milliseconds is consistent with AVNRT, whereas a differential VA interval of less than 20 milliseconds is consistent with orthodromic AVRT.19

Length of Pacing Drive Required for Entrainment

As discussed in Chapter 17, assessing the timing and type of response of SVT to RV pacing can help differentiate orthodromic AVRT from AVNRT. Because the RV pacing site is closer to the reentrant circuit in AVRT than to the AVNRT circuit, RV pacing resets the tachycardia in the setting of AVRT once ventricular capture is achieved, whereas the resetting response is delayed in the setting of AVNRT. Consequently, when resetting of the SVT occurs after a single paced QRS complex, orthodromic AVRT is suggested and AVNRT is generally excluded. On the contrary, if resetting occurs only after at least two beats AVNRT is suggested (Fig. 20-9).20

Atrial and Ventricular Electrogram Sequence Following Cessation of Ventricular Pacing

As discussed in Chapter 11, the sequence of atrial and ventricular electrograms following cessation of overdrive ventricular pacing during SVT (without tachycardia termination) can help distinguish between the different mechanisms of SVT. It is necessary to verify the presence of 1:1 VA conduction during ventricular pacing before analyzing electrogram sequence. In the setting of AVNRT and orthodromic AVRT, the electrogram sequence immediately after the last paced QRS complex is atrial-ventricular (i.e., “A-V response”; see Fig. 11-14). In contrast, in the setting of AT, cessation of overdrive ventricular pacing is followed by an atrial-atrial-ventricular electrogram sequence (i.e., an “A-A-V response”; see Fig. 11-14).22

Importantly, a pseudo–A-A-V response can occur: (1) during atypical AVNRT, (2) when 1:1 VA conduction is absent during overdrive ventricular pacing, (3) during typical AVNRT with long His bundle–ventricular (HV) or short HA intervals whereby atrial activation may precede ventricular activation, and (4) in patients with a bystander BT (Fig. 20-10). Replacing ventricular activation with HB activation (i.e., characterizing the response as A-A-H or A-H instead of A-A-V or A-V, respectively) can be more accurate and can help eliminate the pseudo–A-A-V response in patients with AVNRT and long HV intervals, short HA intervals, or both (see Fig. 20-8). On the other hand, a pseudo–A-V response can occur with automatic AT when the maneuver is performed during isoproterenol infusion, and can theoretically occur when AT coexists with retrograde dual AVN pathways or bystander BT (see Chap. 11).22

Diagnostic Maneuvers during Normal Sinus Rhythm after Tachycardia Termination

When pacing the atrium or ventricle at the tachycardia CL, it is important that the autonomic tone be similar to its state during the tachycardia, because alterations of autonomic tone can independently influence AV or VA conduction.

Ventricular Pacing at the Tachycardia Cycle Length

His Bundle–Atrial Interval

Ventricular pacing during NSR at a CL similar to the tachycardia results in HA and VA intervals that are shorter than those during orthodromic AVRT (see Fig. 18-30). Contrariwise, in the setting of AVNRT, ventricular pacing at the tachycardia CL results in HA and VA intervals that are equal or longer during pacing than those during the SVT (see Fig. 17-20). To help distinguish between orthodromic AVRT and AVNRT, the HA interval is measured from the end of the His potential (where the impulse leaves the HB to enter the AVN) to the atrial electrogram in the high RA recording and the ΔHA interval (HApacing – HASVT) is calculated. In the setting of orthodromic AVRT, the ΔHA interval is typically less than –10 milliseconds; whereas, in the setting of AVNRT, the ΔHA interval is more than –10 milliseconds. When the retrograde His potential is not visualized, using the ΔVA interval instead of the ΔHA interval is not as accurate in discriminating orthodromic AVRT from AVNRT (see Chap. 17).23

Practical Approach to Electrophysiological Diagnosis of Supraventricular Tachycardia

It is important to understand that there is no single diagnostic maneuver or algorithm that is adequate in distinguishing between the different types of SVTs in all cases. Each maneuver has its own applications and limitations. Although several diagnostic criteria were found to have high specificity, sensitivity is frequently limited. Therefore, the investigator will often need to use a combination of SVT features and pacing maneuvers to establish an accurate diagnosis. Systematic evaluation of all possibilities and adherence to fundamental EP principles will help establish the correct diagnosis. Each step during the EP study in these patients can offer valuable information to the vigilant investigator that, if recognized, can potentially reduce procedure time and improve outcome.

Tables 20-1, 20-2, and 20-3 and Figure 20-11 outline some of the proposed strategies for the EP diagnosis of narrow complex SVTs. Baseline tachycardia features, atrial and ventricular programmed stimulation during the tachycardia and then during sinus rhythm after tachycardia termination, provide a diagnosis of the mechanism of SVT in the vast majority of cases.

TABLE 20-1 Diagnostic Strategy for Narrow QRS Supraventricular Tachycardia: Tachycardia Features

Atrial activation sequence

VA interval AV block VA block Effects of BBB Tachycardia CL variations Tachycardia termination

A-A = atrial-atrial; AT = atrial tachycardia; AV = atrioventricular; AVNRT = atrioventricular nodal reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia; BBB = bundle branch block; BT = bypass tract; CL = cycle length; PAC = premature atrial complex; PJRT = permanent junctional reciprocating tachycardia; RA = right atrium; SVT = supraventricular tachycardia; VA = ventriculoatrial.

TABLE 20-2 Diagnostic Strategy for Narrow QRS Supraventricular Tachycardia: Programmed Electrical Stimulation during Tachycardia

Ventricular Extrastimulation
When the VES advances the next atrial activation
When the VES delays the next atrial activation
When the VES terminates the SVT
When the VES fails to affect the next atrial activation
Ventricular Pacing
VA dissociation
VA interval
Post-pacing interval
Entrainment with ventricular fusion
Differential right ventricular entrainment
Length of pacing drive required for entrainment
Atrial activation sequence during ventricular pacing
Atrial and ventricular electrogram sequence following cessation of ventricular pacing
Atrial Pacing
Entrainment during atrial pacing
Entrainment with atrial fusion
Overdrive suppression
AH interval
VA linking
Differential site atrial pacing

A-A = atrial-atrial; A-A-V = atrial-atrial-ventricular; AH = atrial-His bundle interval; AT = atrial tachycardia; AV = atrioventricular; AVNRT = atrioventricular nodal reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia; BT = bypass tract; CL = cycle length; CS = coronary sinus; HB = His bundle; PPI = post-pacing interval; RA = right atrium; RV = right ventricle; SVT = supraventricular tachycardia; VA = ventriculoatrial; VES = ventricular extrastimulus.

TABLE 20-3 Diagnostic Strategy for Narrow QRS Supraventricular Tachycardia: Programmed Electrical Stimulation during Sinus Rhythm

Ventricular Pacing from Right Ventricular Apex at Tachycardia Cycle Length
HA interval
Retrograde atrial activation sequence
VA block
Atrial Pacing from High Right Atrium at Tachycardia Cycle Length
AH interval
AV block
Differential Right Ventricular Pacing
VA interval
Atrial activation sequence
Para-Hisian Pacing
Atrial activation sequence
HA and VA intervals

AH = atrial-His bundle interval; AT = atrial tachycardia; AV = atrioventricular; AVN = atrioventricular node; AVNRT = atrioventricular nodal reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia; BT = bypass tract; CL = cycle length; HA = His bundle–atrial interval; RB = right bundle branch; RV = right ventricle; S-A = stimulus-atrial interval; SVT = supraventricular tachycardia; VA = ventriculoatrial.

When sustained SVT is inducible, overdrive pacing from the RV apex and base is performed at a CL 10 to 30 milliseconds shorter than the tachycardia CL; the pacing CL is then progressively reduced by 10 to 20 milliseconds in a stepwise fashion with discontinuation of ventricular pacing after each pacing CL to verify continuation versus termination of the SVT. When acceleration of the atrial CL to the pacing CL during ventricular pacing (with 1:1 VA conduction) is verified, several diagnostic criteria can be applied (see Table 20-2). Overdrive ventricular pacing during the SVT represents the single most important diagnostic maneuver that can provide several clues to the diagnosis of most SVTs. Therefore, it is preferable to employ this maneuver as an initial step in the diagnostic approach.26

Subsequently, a VES is delivered when the HB is refractory and then at progressively shorter VES coupling intervals (approximately 10-millisecond stepwise shortening of the VES coupling interval) so as to scan all of diastole. First, ventricular capture of the VES should be verified, and then the effect of the VES on the following atrial activation (advancement, delay, termination, or no effect) should be evaluated, as well as the timing of the VES in relation to the expected His potential during the SVT. Furthermore, conduction of the VES to the atrium and sequence of atrial activation following the VES should be carefully examined (see Fig. 20-6).

Atrial pacing is then performed at a CL 10 to 20 milliseconds shorter than the tachycardia CL. The pacing CL is then progressively reduced by 10 to 20 milliseconds in a stepwise fashion, with discontinuation of atrial pacing after each pacing CL to ensure continuation versus termination of the SVT. The presence of entrainment, atrial fusion, AH interval, and VA linking should be evaluated (see Table 20-2).

After tachycardia termination, ventricular and atrial pacing at the tachycardia CL, differential site RV pacing (RV apex versus base), and para-Hisian pacing maneuvers are performed (see Table 20-3).

References

1. Lau E.W. Infraatrial supraventricular tachycardias: mechanisms, diagnosis, and management. Pacing Clin Electrophysiol. 2008;31:490-498.

2. Porter M.J., Morton J.B., Denman R., et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1:393-396.

3. Gonzalez-Torrecilla E., Almendral J., Arenal A., et al. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol. 2009;53:2353-2358.

4. Ballo P., Bernabo D., Faraguti S.A. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Eur Heart J. 2004;25:1310-1317.

5. Blomstrom-Lundqvist C., Scheinman M.M., Aliot E.M., et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493-1531.

6. Knight B.P., Ebinger M., Oral H., et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2000;36:574-582.

7. Kertesz N.J., Fogel R.I., Prystowsky E.N. Mechanism of induction of atrioventricular node reentry by simultaneous anterograde conduction over the fast and slow pathways. J Cardiovasc Electrophysiol. 2005;16:251-255.

8. Kapa S., Henz B.D., Dib C., et al. Utilization of retrograde right bundle branch block to differentiate atrioventricular nodal from accessory pathway conduction. J Cardiovasc Electrophysiol. 2009;20:751-758.

9. Josephson M.E. Supraventricular tachycardias. In: Josephson M.E., editor. Clinical cardiac electrophysiology. ed 4. Philadelphia: Lippincott Williams & Wilkins; 2008:175-284.

10. Lockwood D., Nakagawa H., Jackman W. Electrophysiological characteristics of atrioventricular nodal reentrant tachycardia: implications for the reentrant circuit. In: Zipes D.P., Jalife J., editors. Cardiac electrophysiology: from cell to bedside. ed 5. Philadelphia: WB Saunders; 2009:615-646.

11. Issa Z.F. Mechanism of paroxysmal supraventricular tachycardia with ventriculoatrial conduction block. Europace. 2009;11:1235-1237.

12. Morihisa K., Yamabe H., Uemura T., et al. Analysis of atrioventricular nodal reentrant tachycardia with variable ventriculoatrial block: characteristics of the upper common pathway. Pacing Clin Electrophysiol. 2009;32:484-493.

13. Srivathsan K., Gami A.S., Barrett R., et al. Differentiating atrioventricular nodal reentrant tachycardia from junctional tachycardia: novel application of the delta H-A interval. J Cardiovasc Electrophysiol. 2008;19:1-6.

14. Maruyama M., Kobayashi Y., Miyauchi Y., et al. The VA relationship after differential atrial overdrive pacing: a novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol. 2007;18:1127-1133.

15. Kannankeril P.J., Bonney W.J., Dzurik M.V., Fish F.A. Entrainment to distinguish orthodromic reciprocating tachycardia from atrioventricular nodal reentry tachycardia in children. Pacing Clin Electrophysiol. 2010;33:469-474.

16. Platonov M., Schroeder K., Veenhuyzen G.D. Differential entrainment: beware from where you pace. Heart Rhythm. 2007;4:1097-1099.

17. Gonzalez-Torrecilla E., Arenal A., Atienza F., et al. First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. Heart Rhythm. 2006;3:674-679.

18. Veenhuyzen G.D., Stuglin C., Zimola K.G., Mitchell L.B. A tale of two post pacing intervals. J Cardiovasc Electrophysiol. 2006;17:687-689.

19. Segal O.R., Gula L.J., Skanes A.C., et al. Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2009;6:493-500.

20. Dandamudi G., Mokabberi R., Assal C., et al. A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2010;7:1326-1329.

21. AlMahameed S.T., Buxton A.E., Michaud G.F. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010;3:578-584.

22. Vijayaraman P., Lee B.P., Kalahasty G., Wood M.A., Ellenbogen K.A. Reanalysis of the “pseudo A-A-V” response to ventricular entrainment of supraventricular tachycardia: importance of His-bundle timing. J Cardiovasc Electrophysiol. 2006;17:25-28.

23. Miller J.M., Rosenthal M.E., Gottlieb C.D., et al. Usefulness of the delta HA interval to accurately distinguish atrioventricular nodal reentry from orthodromic septal bypass tract tachycardias. Am J Cardiol. 1991;68:1037-1044.

24. Nakagawa H., Jackman W.M. Para-Hisian pacing: useful clinical technique to differentiate retrograde conduction between accessory atrioventricular pathways and atrioventricular nodal pathways. Heart Rhythm. 2005;2:667-672.

25. Sauer W.H., Lowery C.M., Cooper J.M., Lewkowiez L. Sequential dual chamber extrastimulation: a novel pacing maneuver to identify the presence of a slowly conducting concealed accessory pathway. Heart Rhythm. 2008;5:248-252.

26. Veenhuyzen G.D., Coverett K., Quinn F.R., et al. Single diagnostic pacing maneuver for supraventricular tachycardia. Heart Rhythm. 2008;5:1152-1158.